1Gonzalez S, Martinez- Borra J, Del Rio JS, et al, The OTF3 gene polymorphism confers susceptibility to psoriasis independent of the association of HLA - Cw * 0602. J Invest Dermatol 2000; 115(5) :824- 828.
2Ameen M, Allen MH, Fisher SA, et al. Corneodesmosin (CDSN) gene association with psoriasis vulgaris in Caucasian but not in Japanese populations. Clin Exp Dermatol 2005;30(4):414- 418.
3Foerster J, Nolte I, Junge J, et al. Haplotype sharing analysis identifies a retroviral dUTPase as candidate susceptibility gene for psoriasis. J Invest Dermatol 2005;124(1):99- 102.
4Gu X, Lundqvist EN, Coates PJ, et al. Dysregulation of TAp63 mRNA and protein levels in psoriasis. J Invest Dermatol 2006; 126( 1): 137- 141.
5Gaspari AA. Innate and adaptive immunity and the pathophysiology of psoriasis. J Am Acad Dermatol 2006;54(3 Suppl 2) :67 - 80.
6Pestelli E, Caproni M, Giomi B, et al. Cetirizine reduces the number of tryptase - positive mast cells in psoriatic patients: a double - blind controlled study. Int J Tissue React 2001 ;.23(3) :97- 103.
7Rocha- Pereira P, Santos - Silva A, Rebelo I, et al. Erythrocyte damage in mild and severe psoriasis. Br J Dermatol 21304;150(2): 232 - 244.
8Mee JB, Cork MJ, Di Giovine FS, et al. Interleukin- 1: a key inflammatory mediator in psoriasis? Cytokine 2006;21 ;33(2) :72- 78.
9Reich K, Garbe C, Blaschke V, et al. Response of psoriasis to interleukin- 10 is associated with suppression of cutaneous type 1 inflammation, downregulation of the epidermal interleukin - 8/CXCR2 pathway and normalization of keratinocyte maturation. J Invest Dermatol 2001 ; 116(2) :319 - 329.
10Kanda N, Koike S, Watanabe S. IL- 17 suppresses TNF- alpha - induced CCLT/ production through induction of COX- 2 in human keratinocytes. J Allergy Clin Immunol 2005;116(5) :1144- 1150.
